Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: GSK Furthers Cancer Gene Therapy Plans Via Lyell Collaboration

Oct 10 2019

• By Joseph Haas and John Davis

DealWatch_1200x675 — GSK delves further into cancer gene therapy

Related Content

Keeping Track: Telework Kept FDA On Track During Blizzard

Feb 01 2016

The Skinny On Labeling For Orexigen’s Contrave

Sep 11 2014

Novo Anticipates Q4 Soft Launch For Closely Watched Oral GLP-1 Agent Rybelsus In The US

Sep 21 2019

Stealth BioTherapeutics Looks Ahead To Phase III In Mitochondrial Disease

Jun 20 2016

Reata Expands Options For Bardoxolone With New CKD Data

Feb 20 2019

Asia Deal Watch: Takeda, Eisai Team With Non-Profit On Review Of Novel Targets For Antibiotics

Dec 12 2018

Pay Day For Reata As Bardoxolone Progresses For Kidney Disease In Japan

Aug 31 2018

Culture Change At GSK: 'We’re Doing What We Said We’d Do'

Oct 09 2019

UCB To Buy Ra for $2.1bn And Plays Down Antitrust Fears

Oct 10 2019

IPO Update: 35 Biopharmas Provide -6.1% Average Return; New Offerings Feel Stock Market Impact

Oct 03 2019

Related Companies

Pfizer Inc.

GSK plc

Bristol Myers Squibb Company

GRAIL Inc.

Avacta Group plc

ADC Therapeutics SA

Moderna, Inc.

LG Chem, Ltd.

Reata Pharmaceuticals, Inc.

AbbVie Inc.

Abbott

Kyowa Kirin Co., Ltd.

Alexion Pharmaceuticals Inc.

Stealth BioTherapeutics Inc.

Neumentum

Merck & Co., Inc.

4D Pharma, plc

Currax Pharmaceuticals LLC

Currax Pharmaceuticals LLC

OptiNose, Inc.

Orexigen Therapeutics, Inc.

Zogenix, Inc.

Somaxon Pharmaceuticals, Inc.

Additional Topics

Deals Business Strategies Commercial M & A BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.